VEGFA and neoplasm: They demonstrated in vivo that low concentrations of RGD-mimetic αvβ3 and αvβ5 inhibitors (cilengitide and S36578) paradoxically promote tumor growth and tumor angiogenesis by promoting VEGF-mediated angiogenesis.